Cell Therapy

Are Enzymes Programmable Molecular Machines?
Research & Development Are Enzymes Programmable Molecular Machines?

The long-held view of enzymes as nature's exquisitely specific but single-minded catalysts is undergoing a profound transformation, giving way to a new paradigm that reimagines them as versatile, programmable molecular machines. This significant shift, fueled by remarkable discoveries in natural

Smooth Muscle Cells: Friend or Foe in Plaque?
Research & Development Smooth Muscle Cells: Friend or Foe in Plaque?

The prevailing view of atherosclerosis has dramatically shifted from a simple plumbing issue of cholesterol buildup to a complex and dangerous chronic inflammatory disease responsible for the vast majority of heart attacks and strokes worldwide. For decades, scientific focus centered on immune

Targeting Pro-Tumor Neutrophils – Review
Research & Development Targeting Pro-Tumor Neutrophils – Review

The intricate landscape of the tumor microenvironment is increasingly recognized not as a simple collection of malignant cells, but as a complex ecosystem where cancer’s fate is dictated by a dynamic interplay with the body's own immune system. The targeting of specific immune cell subsets

Can Immune First Responders Predict Cancer?
Research & Development Can Immune First Responders Predict Cancer?

A significant European collaborative initiative has made remarkable strides in understanding the intricate dance between the body's immune system and the onset of cancer, potentially unlocking a new era of predictive diagnostics. By focusing on the often-overlooked first-line defenders known as

Cancer's Sticky Coat Key to Its Deadly Spread
Research & Development Cancer's Sticky Coat Key to Its Deadly Spread

A baffling contradiction has long stood at the heart of understanding how one of the most aggressive forms of breast cancer spreads throughout the body, but new research has finally unraveled this mystery, revealing a unique survival strategy that cancer cells use to become metastatic. For years,

Mutation Quality, Not Quantity, Drives Cancer Therapy
Research & Development Mutation Quality, Not Quantity, Drives Cancer Therapy

The promise of harnessing the body's own immune system to fight cancer has been one of the most significant medical breakthroughs of the century, yet a persistent paradox has puzzled clinicians and researchers alike. For years, the prevailing wisdom held that tumors with more genetic mutations were

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later